CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Bedside lung ultrasoundWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D011024 Pneumonia, Viral NIH 0.14
D011014 Pneumonia NIH 0.07

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.07

There is one clinical trial.

Clinical Trials

1 The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 at Emergency Department

Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .

NCT04399681 COVID Pneumonia, Viral Device: Bedside lung ultrasound
MeSH:Pneumonia, Viral Pneumonia

Primary Outcomes

Description: Efficacy of POCUS on diagnosis of viral pneumonia caused by COVID 19

Measure: Presence of viral pneumonia caused by COVID 19

Time: 3 months

Related HPO nodes (Using clinical trials)